Biotech giant Illumina will unwind takeover of cancer-screening company Grail
SAN DIEGO, Calif. (AP) - Biotech giant Illumina says it will undo its $7.1 billion purchase of the cancer-screening company Grail after losing legal battles with antitrust enforcer…
